Orexo AB (FRA:C5G) Other Operating Expense : €-2.46 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Orexo AB Other Operating Expense?

Orexo AB's Other Operating Expense for the three months ended in Mar. 2025 was €0.51 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €-2.46 Mil.

Orexo AB's quarterly Other Operating Expense declined from Sep. 2024 (€0.22 Mil) to Dec. 2024 (€-2.73 Mil) but then increased from Dec. 2024 (€-2.73 Mil) to Mar. 2025 (€0.51 Mil).

Orexo AB's annual Other Operating Expense declined from Dec. 2022 (€1.51 Mil) to Dec. 2023 (€-1.27 Mil) and declined from Dec. 2023 (€-1.27 Mil) to Dec. 2024 (€-2.83 Mil).

Orexo AB Other Operating Expense Historical Data

The historical data trend for Orexo AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Other Operating Expense Chart

Orexo AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

2.10

0.66

1.51

-1.27

-2.83

Orexo AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-0.38	-0.46	0.22	-2.73	0.51

Orexo AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.46 Mil.

Orexo AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Orexo AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Orexo AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (FRA:C5G) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

ORX:Sweden 0H19:UK C5G:Germany

Address

Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105

Website

https://www.orexo.com

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB Headlines

No Headlines